4th International Conference on Hepatology

Hepatology 2017

Posted on 2016-11-07 by Hepatology2017 in Healthcare, Non Profit // 0 Comments

Exploring Emerging Markets in Hepatology

International Hepatology Conference Series

Los Angeles, CA, 2016-Nov-07 — /EPR Network/ — Conference Series has been instrumental in conducting international gastroenterology & Hepatology meetings for three years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Madrid, Chicago, and Dubai with success the meetings again scheduled in three continents. 4^th International Conference on Hepatology meeting going to be held during April 27-28, 2017 at Dubai, UAE. 5th World Congress on Hepatitis & Liver Diseases Scheduled in August 10-12, 2017 London, UK. 13th International Conference on Clinical Gastroenterology and Hepatology planned to be conduct in Nov 13-15, 2017 Las Vegas, USA.

Hepatology Market report involves committed segments focusing on the territorial market income and patterns. The Hepatology Market showcase has been fragmented on the premise of geographic locales into North America, Europe, Asia Pacific and Rest of the World (RoW). Hepatology Market gauges have additionally been accommodated the authentic years 2013 and 2014 alongside estimate for the period from 2015 – 2022. Nearly 10% of the US Americans (25 Million) are afflicted with liver-related diseases each year. Chronic liver diseases are the biggest problem. An estimated 30% of the world’s total population (2 billion) has been infected with hepatitis B virus and more than 350 million people (perhaps 400) are inflicted by chronic HBV. About 170 million persons have hepatitis C. The global liver disease therapeutics market totalled $24.5 billion in 2014, with the U.S. contributing $9.1 billion, and is anticipating a global market of $33.8 billion by 2019, according to a press release.

Timothy Block, PhD, President and Co-founder of the Hepatitis B Foundation points out that hepatitis C, once thought to be incurable, is today cured with new combination treatments. “Treatments are available,” explained Block, “but we have become a little too comfortable with the medications that are currently approved for use.” These drugs work in only half of the infected population and reduce death rates by only about 40 to 70 percent.

Everyone interested in the future of emerging – healthcare techniques majorly in hepatology, gastroenterology and internal medicine are encouraged to attend. Connect with our social network pages to get regular industry updates.

About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.

Matched content

Editor’s pick